Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
CA Stock MarketDetailed Quotes
InnoCan Pharma Corp (INNO)
- 8.000
- -0.100-1.23%
15min DelayMarket Closed Jan 16 12:35 ET
35.99MMarket Cap-6.92P/E (TTM)
8.000High7.890Low1.35KVolume7.890Open8.100Prev Close10.63KTurnover21.00052wk High0.04%Turnover Ratio4.50MShares6.66052wk Low-1.156EPS TTM28.64MFloat Cap107.250Historical HighLossP/E (Static)3.58MShs Float3.250Historical Low-0.935EPS LYR1.36%Range %--Dividend TTM6.72P/B1Lot Size--Div Yield TTM
InnoCan Pharma Corp (INNO) Cash Flow
Quarterly+Annual
YOY
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 102.19%22K | 1.63%686K | 149.26%368K | 59.55%-1.58M | 61.56%-504K | -39.69%-1M | 194.67%675K | 35.71%-747K | 35.65%-3.9M | 3.89%-1.31M |
| Net income from continuing operations | -681.69%-1.65M | -132.95%-315K | 84.25%-229K | 93.83%-262K | 93.97%-48K | 115.54%284K | 340.81%956K | -18.40%-1.45M | -9.23%-4.25M | 31.97%-796K |
| Operating gains losses | 158.65%200K | ---- | ---- | -958.53%-2.22M | -192.45%-775K | -156.55%-341K | -13,112.50%-1.06M | 41.67%-42K | 109.30%258K | -33.84%-265K |
| Depreciation and amortization | 22.22%11K | -10.00%9K | 0.00%10K | 6.06%35K | -25.00%6K | 0.00%9K | 11.11%10K | 42.86%10K | -5.71%33K | -38.46%8K |
| Remuneration paid in stock | 621.72%1.6M | -93.92%23K | -91.78%95K | 135.01%2.01M | 154.55%252K | -60.61%221K | 519.67%378K | 769.17%1.16M | -11.69%854K | -26.12%99K |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -145.00%-9K | ---- | ---- |
| Change In working capital | 43.31%-907K | 149.58%891K | 208.67%489K | -51.70%-1.2M | 267.24%490K | -1,315.93%-1.6M | 197.81%357K | -1,945.45%-450K | -49.34%-793K | -29.65%-293K |
| -Change in receivables | -4,535.29%-754K | 585.71%288K | 1,209.52%466K | 950.00%17K | --0 | 383.33%17K | -51.72%42K | 51.72%-42K | -101.23%-2K | -89.47%4K |
| -Change in inventory | 120.52%157K | 691.53%349K | 142.57%364K | -154.87%-1.57M | 270.31%109K | -186.52%-765K | 56.30%-59K | -470.00%-855K | 0.81%-616K | 60.49%-64K |
| -Change in payables and accrued expense | 16.84%-311K | 89.92%-60K | -76.85%229K | -46.58%86K | 180.49%66K | -310.11%-374K | -296.67%-595K | 360.00%989K | 320.55%161K | 19.61%-82K |
| -Change in other current assets | 82.91%-121K | -67.60%314K | -5.17%-570K | 178.57%264K | 460.93%545K | ---708K | --969K | ---542K | ---336K | ---151K |
| Interest paid (cash flow from operating activities) | 0.80%-746K | ---- | 133.33%3K | ---- | ---- | ---752K | --73K | ---9K | ---8K | ---- |
| Interest received (cash flow from operating activities) | ---- | ---- | --3K | --59K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 102.19%22K | 1.63%686K | 149.26%368K | 59.55%-1.58M | 61.56%-504K | -39.69%-1M | 194.67%675K | 35.71%-747K | 35.65%-3.9M | 3.89%-1.31M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 33.33%-4K | 33.33%-2K | -100.00%-4K | 164.29%54K | 822.22%65K | 80.65%-6K | 70.00%-3K | 94.12%-2K | -170.97%-84K | 43.75%-9K |
| Net PPE purchase and sale | 33.33%-4K | 66.67%-1K | -150.00%-5K | 67.39%-15K | 55.56%-4K | ---6K | 70.00%-3K | 92.59%-2K | -76.92%-46K | 18.18%-9K |
| Net other investing changes | ---- | ---- | --1K | 281.58%69K | ---- | ---- | ---- | ---- | -660.00%-38K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 33.33%-4K | 33.33%-2K | -100.00%-4K | 164.29%54K | 822.22%65K | 81.25%-6K | 66.67%-3K | 94.12%-2K | -170.97%-84K | 43.75%-9K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -100.35%-3K | 3,160.00%153K | -31.31%996K | -7.30%2.7M | -64.22%400K | -40.68%859K | 16.67%-5K | 306.16%1.45M | 2,233.60%2.92M | 56,000.00%1.12M |
| Net issuance payments of debt | 50.00%-3K | 20.00%-4K | 12,820.00%636K | 0.00%-22K | -20.00%-6K | -20.00%-6K | 16.67%-5K | 16.67%-5K | -100.00%-22K | -150.00%-5K |
| Net common stock issuance | --0 | --93K | --0 | -42.70%891K | -121.06%-123K | -48.16%395K | --0 | 196.17%619K | --1.56M | --584K |
| Proceeds from stock option exercised by employees | --0 | --64K | -56.94%360K | 32.59%1.84M | -1.86%529K | -31.98%470K | --0 | 442.86%836K | 917.65%1.38M | --539K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -100.35%-3K | 3,160.00%153K | -31.31%996K | -7.30%2.7M | -64.22%400K | -40.68%859K | 16.67%-5K | 306.16%1.45M | 2,233.60%2.92M | 56,000.00%1.12M |
| Net cash flow | ||||||||||
| Beginning cash position | 39.81%7.26M | 38.52%6.37M | 28.91%5.01M | -21.47%3.89M | 25.67%5.06M | 53.84%5.19M | 12.37%4.6M | -21.47%3.89M | -55.22%4.95M | -37.28%4.02M |
| Current changes in cash | 110.00%15K | 25.49%837K | 94.01%1.36M | 210.08%1.18M | 80.69%-39K | -121.49%-150K | 191.62%667K | 183.55%701K | 82.07%-1.07M | 85.38%-202K |
| Effect of exchange rate changes | --0 | 172.60%53K | -133.33%-3K | -722.22%-56K | -115.87%-10K | 138.30%18K | -708.33%-73K | 147.37%9K | 107.03%9K | 172.41%63K |
| End cash Position | 43.76%7.27M | 39.81%7.26M | 38.52%6.37M | 28.91%5.01M | 28.91%5.01M | 25.67%5.06M | 53.84%5.19M | 12.37%4.6M | -21.47%3.89M | -21.47%3.89M |
| Free cash from | 101.78%18K | 1.93%685K | 148.46%363K | 59.65%-1.59M | 61.52%-508K | -40.53%-1.01M | 192.95%672K | 37.01%-749K | 35.17%-3.95M | 4.00%-1.32M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"